Health library

Type 2 Diabetes Medications Compared: Metformin, Sulfonylureas, and the Other First-Line Options

Five oral drug classes make up the first-line toolkit for type 2 diabetes, and metformin dominates that group so thoroughly that the other four rarely get much explanation. This guide covers how each class works, what real people ask most about metformin specifically, side effects, weight, alcohol, and cost, and how the other options differ when metformin alone isn't enough.

Metformin: Why It’s First-Line for Almost Everyone

Metformin is the starting point for most people diagnosed with type 2 diabetes because it offers a combination few other options match: real effectiveness, a long safety track record, low cost, and a favorable weight profile compared to older alternatives. Current ADA guidance adds an important exception: people with heart disease, heart failure, or chronic kidney disease are often started early on an SGLT2 inhibitor or GLP-1 medication, alongside or even before metformin, because of their proven heart and kidney benefits. It works primarily by reducing how much glucose the liver releases between meals, the main driver of elevated fasting blood sugar, while modestly improving how the body’s own tissues respond to insulin.

Metformin Side Effects

Digestive side effects, diarrhea, nausea, gas, and stomach discomfort, are the most common reasons metformin feels hard to tolerate, and they are most noticeable in the first weeks or right after a dose increase.

The difference between formulations is dramatic: in one comparison, roughly half of people taking immediate-release metformin reported diarrhea, compared to roughly 1 in 10 on the extended-release version. Taking it with food and starting at a low dose both help considerably, regardless of which form is used.

The serious risk to know about is lactic acidosis, a rare but genuine emergency where acid builds up in the blood. It affects roughly 19 per 100,000 patient-years, and risk concentrates heavily in people with significant kidney or liver impairment, which is why kidney function is checked before starting and periodically afterward. Metformin is not used when kidney function falls below an eGFR of 30, and it is typically paused around procedures that use iodinated contrast dye.

Moderate alcohol use is generally considered fine, but heavy or excessive drinking raises the risk of lactic acidosis specifically and is worth discussing directly with a prescriber rather than guessing at what counts as too much.

Metformin and Weight

Metformin is not a weight-loss drug, but it tends to produce a modest effect in that direction, rather than the weight gain associated with some older diabetes medications. Across clinical studies, average loss typically runs around 2 to 4 kilograms (roughly 4 to 9 pounds) over 6 to 12 months, with meaningful variation between individuals and some people losing little or nothing.

The Diabetes Prevention Program, the same landmark trial covered in our article on prediabetes, found that metformin produced early weight loss on that order. And a long-term follow-up of the same participants found that loss held up remarkably well, with the metformin group maintaining roughly 6 percent weight loss on average between years 6 and 15.

The mechanism runs through reduced appetite and lower circulating insulin rather than direct fat burning, and it appears to modestly raise the same gut hormone, GLP-1, that our article on newer diabetes medications covers in far more depth. Metformin’s weight effect is real but genuinely small compared with GLP-1 medications, which produce substantially more weight loss for people for whom that is the primary goal.

The Other First-Line Options

When metformin alone is not enough or is not tolerated, these are the other classes most commonly added or substituted.

Sulfonylureas: Glimepiride and Glipizide

These stimulate the pancreas to release more insulin, making them effective but introducing two trade-offs metformin does not carry: risk of hypoglycemia, especially if a meal is skipped, and a tendency toward weight gain rather than loss. Glipizide and glimepiride are generally preferred within this class over older sulfonylureas because they carry a comparatively lower hypoglycemia risk.

Pioglitazone

This works by improving how muscle and fat tissue respond to insulin rather than increasing insulin output. It does not typically cause hypoglycemia on its own, but fluid retention, weight gain, and an increased risk of heart failure are real enough concerns that it is avoided entirely in people with significant existing heart failure. It is also linked to a higher risk of bone fractures, particularly in women.

Sitagliptin

A DPP-4 inhibitor, sitagliptin, extends the action of the same gut hormones that metformin modestly boosts, helping insulin release rise specifically when blood sugar is elevated after a meal. It is generally weight-neutral and does not cause hypoglycemia on its own, which makes it a comparatively gentle add-on option, though it is usually a smaller effect than the other classes here. Its dose is lowered when kidney function is reduced.

Cost and Long-Term Use

Metformin is inexpensive as generics go, and cost is rarely the reason someone avoids it. A standard 30-day supply of generic metformin typically costs about $14 without insurance at most pharmacies, well under most brand-name diabetes drugs, and a pharmacy discount coupon can lower that to roughly $9 in many cases.

Over the long term, the main thing to monitor is vitamin B12, since metformin can gradually lower levels over years of use; a simple periodic blood test can catch this before it becomes symptomatic. Never stop metformin on your own without talking to your prescriber first, since doing so can let blood sugar rise unpredictably, and any change in treatment is safer managed as a planned transition than an abrupt stop.

Where to Start

If side effects are the issue, ask specifically about switching to extended-release before assuming metformin itself is not a fit, since that single change resolves digestive intolerance for a large share of people who struggle with the immediate-release version. If cost is a concern, ask your pharmacy directly about generic pricing and any manufacturer savings programs before assuming a newer, more expensive drug is the only option.